1. Home
  2. DGAC vs CNXU Comparison

DGAC vs CNXU Comparison

Compare DGAC & CNXU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

DGAC

Disciplined Growth Acquisition Corporation

N/A

Current Price

$9.96

Market Cap

224.5M

Sector

N/A

ML Signal

N/A

Logo Conexeu Sciences Inc. Common Stock

CNXU

Conexeu Sciences Inc. Common Stock

N/A

Current Price

$8.98

Market Cap

215.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DGAC
CNXU
Founded
N/A
N/A
Country
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
224.5M
215.9M
IPO Year
2026
2025

Fundamental Metrics

Financial Performance
Metric
DGAC
CNXU
Price
$9.96
$8.98
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
211.3K
124.1K
Earning Date
N/A
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.85
$6.85
52 Week High
$10.00
$13.66

Technical Indicators

Market Signals
Indicator
DGAC
CNXU
Relative Strength Index (RSI) 69.03 49.44
Support Level $9.85 $7.55
Resistance Level $10.00 $10.35
Average True Range (ATR) 0.02 1.12
MACD 0.00 0.09
Stochastic Oscillator 100.00 58.00

Price Performance

Historical Comparison
DGAC
CNXU

About DGAC Disciplined Growth Acquisition Corporation

Disciplined Growth Acquisition Corp is a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.

About CNXU Conexeu Sciences Inc. Common Stock

Conexeu Sciences Inc is an early-stage medical technology company. The company develops and supplies collagen-based technologies that helps doctors and patients regenerate tissue naturally, safely, and effectively. The company is focused on developing regenerative biomaterials that address relative needs in wound care, dentistry, and aesthetics. The company seek to provide physicians with device-based solutions that improve healing, restore soft tissue, and enhance patient outcomes across multiple clinical settings. The company focuses durable, and growing addressable markets in regenerative aesthetics, wound care, 3D-printed tissue structures, veterinary wound repair, and dental soft-tissue regeneration.

Share on Social Networks: